Literature DB >> 16233795

Solubilization and refolding of bacterial inclusion body proteins.

Surinder Mohan Singh1, Amulya Kumar Panda.   

Abstract

Inclusion bodies produced in Escherichia coli are composed of densely packed denatured protein molecules in the form of particles. Refolding of inclusion body proteins into bioactive forms is cumbersome, results in poor recovery and accounts for the major cost in production of recombinant proteins from E. coli. With new information available on the structure and function of protein aggregates in bacterial inclusion bodies, it has been possible to develop improved solubilization and refolding procedures for higher recovery of bioactive protein. Inclusion bodies are formed from partially folded protein intermediates and are composed of aggregates of mostly single types of polypeptide. This helps to isolate and purify the protein aggregates to homogeneity before solubilization and refolding. Proteins inside inclusion body aggregates have native-like secondary structures. It is assumed that restoration of this native-like secondary structure using mild solubilization conditions will help in improved recovery of bioactive protein in comparison to solubilization using a high concentration of chaotropic agent. Analysis of the dominant forces causing aggregation during inclusion body formation provides information to develop suitable mild solubilization procedures for inclusion body proteins. Refolding from such solubilized protein will be very high due to restoration of native-like secondary structure. Human growth hormone inclusion bodies were purified to homogeneity from E. coli cells before solubilization and refolding. Pure inclusion bodies were solubilized at alkaline pH in the presence of 2 M urea solution. The solubilized proteins were refolded using a pulsatile renaturation process and subsequently purified using chromatographic procedures. More than 40% of the inclusion body proteins could be refolded back to the bioactive native conformation. Mild solubilization is thus the key for high recovery of bioactive protein from inclusion bodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16233795     DOI: 10.1263/jbb.99.303

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  156 in total

1.  Characterization of alcohol dehydrogenase (ADH12) from Haloarcula marismortui, an extreme halophile from the Dead Sea.

Authors:  Leanne M Timpson; Diya Alsafadi; Cillín Mac Donnchadha; Susan Liddell; Michael A Sharkey; Francesca Paradisi
Journal:  Extremophiles       Date:  2011-10-21       Impact factor: 2.395

Review 2.  Architecture and active site of particulate methane monooxygenase.

Authors:  Megen A Culpepper; Amy C Rosenzweig
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-06-23       Impact factor: 8.250

3.  A simplified method for the efficient purification and refolding of recombinant human TRAIL.

Authors:  Zhenjiang Zhang; Su Bin Hahn; Thong M Cao; Michael R King
Journal:  Biotechnol Prog       Date:  2020-05-11

4.  Expression and Activity Analysis of Fructosyltransferase from Aspergillus oryzae.

Authors:  Lihong Guan; Liping Chen; Yongsen Chen; Nu Zhang; Yawei Han
Journal:  Protein J       Date:  2017-08       Impact factor: 2.371

5.  Efficient solubilization, purification of recombinant extracellular alpha-amylase from pyrococcus furiosus expressed as inclusion bodies in Escherichia coli.

Authors:  Lisa Wang; Qinhua Zhou; Huayou Chen; Zhongmei Chu; Jianfeng Lu; Yi Zhang; Shengli Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2006-11-22       Impact factor: 3.346

6.  Increased yield of high purity recombinant human interferon-gamma utilizing reversed phase column chromatography.

Authors:  Praveen K Reddy; Srinivasa G Reddy; Venkata R Narala; Sangita S Majee; Sudhakar Konda; Sripad Gunwar; Raju C Reddy
Journal:  Protein Expr Purif       Date:  2006-09-06       Impact factor: 1.650

7.  Localization of functional polypeptides in bacterial inclusion bodies.

Authors:  Elena García-Fruitós; Anna Arís; Antonio Villaverde
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

Review 8.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

9.  Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae.

Authors:  K L Ostberg; M W Russell; T F Murphy
Journal:  Mucosal Immunol       Date:  2008-10-29       Impact factor: 7.313

Review 10.  Developments in purification methods for obtaining and evaluation of collagen derived endogenous angioinhibitors.

Authors:  Venugopal Gunda; Raj K Verma; Smita C Pawar; Yakkanti A Sudhakar
Journal:  Protein Expr Purif       Date:  2013-11-09       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.